LanzaTech

LanzaTech

LanzaTech was founded in 2005 in New Zealand by Dr. Sean Simpson, emerging from deep biotech research aimed at producing fuel ethanol from industrial waste gases. The venture was operationally scaled after relocating its headquarters to Illinois, with CEO Jennifer Holmgren, a former senior executive at UOP and Honeywell, driving its commercial strategy and its 2023 public listing on Nasdaq under the ticker LNZA. The company's foundational intellectual property covers a proprietary microbe that consumes carbon monoxide, carbon dioxide, and hydrogen from off-gases, converting them into chemicals and fuels that would otherwise be produced from virgin fossil resources. The core commercial structure is an asset-licensing and joint-engineering model rather than a fund or managed account. LanzaTech designs, builds, and licenses gas-fermentation units that sit on host sites operated by corporate partners including ArcelorMittal, IndianOil, and Sinopec. Its first commercial-scale plant was commissioned at a Shougang Group steel mill in China in 2018, demonstrating the ability to capture carbon-rich waste gas and produce ethanol at scale. The company has since expanded operations into Europe and India, targeting the chemicals sector at large through a partnership with BASF. A critical offshoot, LanzaJet, was established with backing from Suncor Energy and British Airways to commercialize an Alcohol-to-Jet pathway, bridging the industrial-gas-to-ethanol chain into drop-in sustainable aviation fuel. With a direct workforce that has fluctuated but remained sub-400 employees, the company's scale is measured less by headcount and more by licensed capacity and a project-development pipeline. Holmgren has been public about a project backlog exceeding $1 billion, though financial realization depends on achieving commercial-scale continuous production at partner sites. In late 2023, the firm secured a commitment from Technip Energies to support integrated project delivery, a shift toward a replicable design-one-build-many model. February 2024 saw the company complete a $40 million registered direct offering to shore up near-term liquidity while accelerating its synthetic biology capabilities for producing acetone and isopropanol through gas fermentation. Structurally, LanzaTech is differentiated by its public listing and mission orientation as a non-venture, non-fund entity. It does not raise external pools of capital to deploy; rather, it commercializes a physical technology suite that other industrial operators adopt. This architecture makes it a licensing and IP company with a dual revenue stream from engineering services contracts and long-term royalty arrangements on ethanol output from licensed plants. Its governance is split between the main commercial board and a subsidiary oversight structure for LanzaJet, which itself has attracted project-finance capital from investors including Microsoft's Climate Innovation Fund, isolating jet-fuel scale-up risk from the core gas-to-ethanol business.